MT

Marc-Olivier Turgeon

Senior Associate at Forbion | Ph.D. in Oncology

Amsterdam, North Holland

Invests in

Stages:

Sectors:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2021

  • Senior Associate

    2024

  • Associate

    2022 - 2024

    Board observer at Pheon Therapeutics

  • Analyst

    2021 - 2022

    Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies with technologies and products designed to transform people’s lives.

  • Postdoctoral Research Fellow

    2020 - 2021

  • Researcher PHD Student

    2016 - 2020

    Research project in Dr. George Poulogiannis’s lab, focused on investigating breast cancer metabolic vulnerabilities to potentially unveil new targets to improve patient care. Important skills developed are efficient time management and self-motivation, critical thinking and experimental design.

2017 - 2019

  • Principal

    2018 - 2019

    Fulfilled the functions mentioned as part of the Structured Stream Lead role (see below), while also overseeing a team of three people developing the technology translation capacity of PanaceaStars and improving the marketing strategy. Additionally, interacted with investors and was the main point of contact for the rebranding of PanaceaStars with sub-contractor Studio Lovelock.

  • Structured Stream Lead

    2017 - 2019

    Contributed to the design and delivery of the existing PanaceaStars accelerator programme including event organization, curriculum choice, mentor scouting, portfolio management, and startup support. Lead the development of a new branch of PanaceaStars where projects are sourced from external partners.

  • Research Assistant

    2013 - 2013

    Contributed to a research project in Dr. Diane Boivin’s lab. Interaction with participants in a clinical study on sleep and circadian rhythm.